Lv4
476 积分 2022-06-28 加入
Nanoparticle-mediated blockade of CXCL12/CXCR4 signaling enhances glioblastoma immunotherapy: Monitoring early responses with MRI radiomics
1天前
待确认
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
5天前
已完结
CD8+ T cell exhaustion and cancer immunotherapy
1个月前
已完结
Immune-enhancing effects of glucocorticoids in response to day–night cycles and stress
2个月前
已完结
Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer
2个月前
已完结
CXCL12-CXCR4 mediates CD57+ CD8+ T cell responses in the progression of type 1 diabetes
2个月前
已完结
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control
2个月前
已完结
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
2个月前
已完结
The role of CD4 T cells in rejection of solid tumors
2个月前
已完结
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
2个月前
已完结
皖公网安备34019202002308
